SynthesisBMC cancer2025
A systematic literature review on mammography: deep learning techniques for breast cancer detection with global and Asian perspectives.
Synthesis in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Enhanced breast cancer detection framework based on YOLOv11n with multi-scale feature calibration.Scientific reports · 2026Article
- An Integrated Statistical and Machine Learning Approach for Breast Cancer Classification Using Tumor Morphological Features.BioMed research international · 2026Article
- High-risk without safeguards? The EU AI Act and the push for deregulation of medical AI.BMJ digital health & AI · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeBreast cancer remains a leading cause of mortality in women worldwide, with notable disparities in incidence and prognosis across regions. This systematic review explores the application of Deep Learning-based computer-aided diagnostic (CAD) systems for breast cancer detection, with a special focus on Asia to highlight underrepresented perspectives and challenges.
methodsWe conducted a systematic Literature review in accordance with PRISMA guidelines. A comprehensive search of Scopus and Web of Science databases was performed to identify relevant studies published between January 2018 and November 2023, with an additional hand search for recent studies from 2024 to 2025. After screening 1051 records, 287 articles were included based on predefined inclusion and exclusion criteria. Quality assessment focused on the relevance of deep learning-based approaches to mammographic breast cancer detection, emphasizing global research trends and focused analysis of studies involving Asian populations.
resultsThe review identified major research trends in deep learning-based mammographic analysis, with most studies focusing on lesion classification while comparatively fewer addressed detection, segmentation, and breast density assessment. Studies using Asian datasets revealed unique challenges, including higher breast density, limited annotations, and under-representation in public datasets. Analysis of methodologies highlighted varied use of image preprocessing and augmentation techniques. Focus maps were used to visualize contributions across tasks and populations, revealing gaps in multi-class BI-RADS classification and a global research bias toward Caucasian datasets (> 80%).
conclusionThis review reveals that most deep learning models for breast cancer detection are trained predominantly on Caucasian datasets, creating significant limitations when applied to other populations due to demographic differences in breast density and imaging characteristics. To improve breast cancer screening globally, researchers must develop deep learning systems using diverse datasets that represent different populations, validate these models across various ethnic groups, and ensure clinical testing includes women from multiple demographic backgrounds. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD 42,023,478,896.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.